BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15657340)

  • 1. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics as a Key Factor in Prostate Cancer.
    Enikeeva K; Rafikova G; Sharifyanova Y; Mulyukova D; Vanzin A; Pavlov V
    Adv Biol (Weinh); 2024 May; 8(5):e2300520. PubMed ID: 38379272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
    Santos PB; Patel H; Henrique R; Félix A
    World J Clin Oncol; 2020 Feb; 11(2):43-52. PubMed ID: 32133274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell chromatin patterns: an instructive mechanism for DNA hypermethylation?
    Ohm JE; Baylin SB
    Cell Cycle; 2007 May; 6(9):1040-3. PubMed ID: 17457052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of diet in prostate cancer: the epigenetic link.
    Labbé DP; Zadra G; Ebot EM; Mucci LA; Kantoff PW; Loda M; Brown M
    Oncogene; 2015 Sep; 34(36):4683-91. PubMed ID: 25531313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers.
    Rafikova G; Gilyazova I; Enikeeva K; Pavlov V; Kzhyshkowska J
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation in cancer progression.
    Baxter E; Windloch K; Gannon F; Lee JS
    Cell Biosci; 2014; 4():45. PubMed ID: 25949794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation in lung cancer.
    Ramazi S; Daddzadi M; Sahafnejad Z; Allahverdi A
    MedComm (2020); 2023 Dec; 4(6):e401. PubMed ID: 37901797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha Satellite DNA in Targeted Drug Therapy for Prostate Cancer.
    Feliciello I; Ugarković Đ
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.
    Jakopovic M; Thomas A; Balasubramaniam S; Schrump D; Giaccone G; Bates SE
    Front Oncol; 2013 Oct; 3():261. PubMed ID: 24130964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It Takes Two to Tango: The Interplay between Prostate Cancer and Its Microenvironment from an Epigenetic Perspective.
    Zaalberg A; Pottendorfer E; Zwart W; Bergman AM
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary Plant Metabolites Induced Epigenetic Modification as a Novel Strategy for the Management of Prostate Cancer.
    Singh V; Shirbhate E; Kore R; Mishra A; Johariya V; Veerasamy R; Tiwari AK; Rajak H
    Mini Rev Med Chem; 2024 Feb; ():. PubMed ID: 38385496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic changes in human prostate cancer.
    Koochekpour S
    Iran Red Crescent Med J; 2011 Feb; 13(2):80-98. PubMed ID: 22737441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research progress and applications of epigenetic biomarkers in cancer.
    Gao J; Shi W; Wang J; Guan C; Dong Q; Sheng J; Zou X; Xu Z; Ge Y; Yang C; Li J; Bao H; Zhong X; Cui Y
    Front Pharmacol; 2024; 15():1308309. PubMed ID: 38681199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in prostate cancer epidemiology.
    Verma M; Patel P; Verma M
    Cancers (Basel); 2011 Sep; 3(4):3773-98. PubMed ID: 24213111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.
    Hatzimichael E; Lagos K; Sim VR; Briasoulis E; Crook T
    EXCLI J; 2014; 13():954-76. PubMed ID: 26417314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of DNA methylation in prostate cancer development.
    Massie CE; Mills IG; Lynch AG
    J Steroid Biochem Mol Biol; 2017 Feb; 166():1-15. PubMed ID: 27117390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.